Literature DB >> 9467347

The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma.

K Yamada1, R Jordan, M Mori, P M Speight.   

Abstract

OBJECTIVES: To evaluate the expression of E-cadherin, a calcium-dependent cell adhesion molecule, in a retrospective analysis of paraffin embedded tissue specimens of oral squamous cell carcinoma and relationship with the clinical TNM stage and histochemical differentiation.
DESIGN: Paraffin embedded tissue sections of normal oral mucosa (n = 6), oral squamous cell carcinoma (SCC, n = 18) and metastatic lymph nodes (n = 2) were immunostained by a three-stage streptoavidin-biotin immunoperoxidase method using monoclonal antibody. The TNM staging and histochemical grading were done according to the standard criteria.
RESULTS: Normal oral epithelium showed a strongly positive pericellular distribution of E-cadherin in basal, parabasal and spinous layers and no staining was observed in the parakeratinized and cornified layers. In well differentiated SCCs, the centrally located cells in tumour islands showed no staining, but peripheral basally located tumour cells showed positive staining. Poorly differentiated SCCs were devoid of staining. In moderately differentiated SCCs, the staining pattern was found to be one of the following three types: (1) a pattern similar to that of well differentiated SCC; (2) central cells of tumour aggregates were reactive but peripheral cells showed weak to negative reaction; and (3) all cells showed a negative reaction, resembling the poorly differentiated SCC. Fischer exact test showed a statistically significant correlation with loss of E-cadherin and grades of tumour differentiation as well as an advancing T and N stage.
CONCLUSION: The loss of E-cadherin may correlate with advancing T and N stages of the tumour and a poor tumour cell differentiation in oral squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9467347     DOI: 10.1111/j.1601-0825.1997.tb00017.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  5 in total

1.  Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.

Authors:  Marianthi Kyrodimou; Dimitrios Andreadis; Angeliki Drougou; Elsa P Amanatiadou; Lefteris Angelis; Calypso Barbatis; Apostolos Epivatianos; Ioannis S Vizirianakis
Journal:  Clin Oral Investig       Date:  2013-02-22       Impact factor: 3.573

Review 2.  E-Cadherin Signaling in Salivary Gland Development and Autoimmunity.

Authors:  Margherita Sisto; Domenico Ribatti; Sabrina Lisi
Journal:  J Clin Med       Date:  2022-04-17       Impact factor: 4.964

3.  Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.

Authors:  Partheeban Balasundaram; Manoj Kumar Singh; Amit Kumar Dinda; Alok Thakar; Rajni Yadav
Journal:  Diagn Pathol       Date:  2014-07-21       Impact factor: 2.644

Review 4.  Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion.

Authors:  Marina Di Domenico; Antonio Giordano
Journal:  Oncotarget       Date:  2017-05-30

5.  Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?

Authors:  João Adolfo Costa Hanemann; Denise Tostes Oliveira; Suely Nonogaki; Inês Nobuko Nishimoto; Marina Lara de Carli; Gilles Landman; Luiz Paulo Kowalski
Journal:  BMC Cancer       Date:  2014-06-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.